Imaging mouse cancer models in vivo using reporter transgenes

Cold Spring Harbor Protocols

Volumn 2013, Issue 8, 2013, Pages 685-699

  Lyons, Scott K ^a   Patrick, P Stephen ^a   Brindle, Kevin M ^a  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FIREFLY LUCIFERASE;

ANIMAL MODEL; BIOLUMINESCENCE; CANCER MODEL; EDITORIAL; FLUORESCENCE IMAGING; GENE EXPRESSION; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; TRANSGENE; TUMOR VOLUME;

EID: 84881080832     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top069864     Document Type: Editorial

References (103)

1. Aide N, Visser EP, Lheureux S, Heutte N, Szanda I, Hicks RJ. 2012. The motivations and methodology for high-throughput PET imaging of small animals in cancer research. Eur J Nucl Med Mol Imaging 39: 1497-1509.
2. Badr CE, Tannous BA. 2011. Bioluminescence imaging: Progress and applications. Trends Biotechnol 29: 624-633.
3. Bhang HE, Gabrielson KL, Laterra J, Fisher PB, Pomper MG. 2011. Tumorspecific imaging through progression elevated gene-3 promoter-driven gene expression. Nat Med 17: 123-129.
4. Boretius S, Kasper L, Tammer R, Michaelis T, Frahm J. 2009. MRI of cellular layers in mouse brain in vivo. NeuroImage 47: 1252-1260.
5. 13C MR reporter probe system using dynamic nuclear polarization. NMR Biomed 24: 514-520.
6. Chudakov DM, Lukyanov S, Lukyanov KA. 2007. Tracking intracellular protein movements using photoswitchable fluorescent proteins PSCFP2 and Dendra2. Nat Protoc 2: 2024-2032.
7. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. 2005. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7: 109-117.
8. Coppola JM, Ross BD, Rehemtulla A. 2008. Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clin Cancer Res 14: 2492-2501.
9. Cui W, Liu L, Kodibagkar VD, Mason RP. 2010. S-Gal, a novel 1H MRI reporter for β-galactosidase. Magn Reson Med 64: 65-71.
10. 13C magnetic resonance imaging and spectroscopy. Nat Med 13: 1382-1387.
11. Deans AE, Wadghiri YZ, Bernas LM, Yu X, Rutt BK, Turnbull DH. 2006. Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med 56: 51-59.
12. de la Zerda A, Bodapati S, Teed R, May SY, Tabakman SM, Liu Z, Khuri-Yakub BT, Chen X, Dai H, Gambhir SS. 2012. Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice. ACS Nano 6: 4694-4701.
13. DuPage M, Dooley AL, Jacks T. 2009. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4: 1064-1072.
14. Egeblad M, Ewald AJ, Askautrud HA, Truitt ML, Welm BE, Bainbridge E, Peeters G, Krummel MF, Werb Z. 2008. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Dis Model Mech 1: 155-167; discussion 165.
15. Egeblad M, Nakasone ES, Werb Z. 2010. Tumors as organs: Complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
16. Entenberg D, Wyckoff J, Gligorijevic B, Roussos ET, Verkhusha VV, Pollard JW, Condeelis J. 2011. Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat Protoc 6: 1500-1520.
17. Fan-Minogue H, Cao Z, Paulmurugan R, Chan CT, Massoud TF, Felsher DW, Gambhir SS. 2010. Noninvasive molecular imaging of c-Myc activation in living mice. Proc Natl Acad Sci 107: 15892-15897.
18. Filonov GS, Piatkevich KD, Ting LM, Zhang J, Kim K, Verkhusha VV. 2011. Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol 29: 757-761.
19. Gadian DG. 1995. NMR and its applications to living systems. Oxford University Press, Oxford.
20. Gallagher FA, Kettunen MI, Day SE, Hu DE, Ardenkjaer-Larsen JH, Zandt R, Jensen PR, Karlsson M, Golman K, Lerche MH, et al. 2008. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 453: 940-943.
21. Gambhir SS, Bauer E, Black ME, Liang Q, Kokoris MS, Barrio JR, Iyer M, Namavari M, Phelps ME, Herschman HR. 2000. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci 97: 2785-2790.
22. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY. 1983. Transferrin receptors in human tissues: Their distribution and possible clinical relevance. J Clin Pathol 36: 539-545.
23. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET. 2005. A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11: 450-454.
24. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. 2009. Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11: 1287-1296.
25. Gilad AA, McMahon MT, Walczak P, Winnard PT Jr, Raman V, van Laarhoven HW, Skoglund CM, Bulte JW, van Zijl PC. 2007a. Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 25: 217-219.
26. Gilad AA, Winnard PT Jr, van Zijl PC, Bulte JW. 2007b. Developing MR reporter genes: Promises and pitfalls. NMR Biomed 20: 275-290.
27. Goldie SJ, Mulder KW, Tan DW, Lyons SK, Sims AH, Watt FM. 2012. FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis. Cancer Res 72: 3424-3436.
28. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Reader AJ, Vassaux G. 2004. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 9: 436-442.
29. Hasegawa S, Furukawa T, Saga T. 2010. Molecular MR imaging of cancer gene therapy: Ferritin transgene reporter takes the stage. Magn Reson Med Sci 9: 37-47.
30. Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N. 2010. A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol 96: 151-159.
31. Herbison CE, Thorstensen K, Chua AC, Graham RM, Leedman P, Olynyk JK, Trinder D. 2009. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells. Am J Physiol Cell Physiol 297: C1567-C1575.
32. Heyer J, Kwong LN, Lowe SW, Chin L. 2010. Non-germline genetically engineered mouse models for translational cancer research. Nat Rev Cancer 10: 470-480.
33. Hillman EM, Moore A. 2007. All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast. Nat Photon 1: 526-530.
34. Hillman EM, Amoozegar CB, Wang T, McCaslin AF, Bouchard MB, Mansfield J, Levenson RM. 2011. In vivo optical imaging and dynamic contrast methods for biomedical research. Phil Trans A Math Phys Eng Sci 369: 4620-4643.
35. Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, et al. 2003. The transferrin receptor: A potential molecular imaging marker for human cancer. Neoplasia 5: 495-506.
36. Iordanova B, Ahrens ET. 2012. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuro-Image 59: 1004-1012.
37. 13C magnetic resonance detection of carboxypeptidase G2 activity. Magn Reson Med 62: 1300-1304.
38. Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T, Contag PR. 2003. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20: 733-744.
39. Kaida A, Sawai N, Sakaguchi K, Miura M. 2011. Fluorescence kinetics in HeLa cells after treatment with cell cycle arrest inducers visualized with FUCCI (fluorescent ubiquitination-based cell cycle indicator). Cell Biol Int 35: 359-363.
40. Kedrin D, Gligorijevic B, Wyckoff J, Verkhusha VV, Condeelis J, Segall JE, van Rheenen J. 2008. Intravital imaging of metastatic behavior through a mammary imaging window. Nat Methods 5: 1019-1021.
41. Kesarwala AH, Prior JL, Sun J, Harpstrite SE, Sharma V, Piwnica-Worms D. 2006. Second-generation triple reporter for bioluminescence, micropositron emission tomography, and fluorescence imaging. Mol Imaging 5: 465-474.
42. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, Winkler F. 2010. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16: 116-122.
43. Kim SB, Sato M, Tao H. 2009. Split Gaussia luciferase-based bioluminescence template for tracing protein dynamics in living cells. Anal Chem 81: 67-74.
44. Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, Bata A, Campbell K, Coffee R, Gorodinsky A, et al. 2010. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS ONE 5: e9364.
45. Kinahan PE, Hasegawa BH, Beyer T. 2003. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med 33: 166-179.
46. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, et al. 2007. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13: 992-997.
47. Li W, Li F, Huang Q, Shen J, Wolf F, He Y, Liu X, Hu YA, Bedford JS, Li CY. 2011. Quantitative, noninvasive imaging of radiation-induced DNA double-strand breaks in vivo. Cancer Res 71: 4130-4137.
48. Likar Y, Dobrenkov K, Olszewska M, Vider E, Shenker L, Cai S, Pillarsetty N, Hricak H, Ponomarev V. 2008. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs. J Nucl Med 49: 713-720.
49. Liu F, Lunsford EP, Tong J, Ashitate Y, Gibbs SL, Yu J, Choi HS, Henske EP, Frangioni JV. 2012. Real-time monitoring of tumorigenesis, dissemination, and drug response in a preclinical model of lymphangioleiomyomatosis/tuberous sclerosis complex. PLoS ONE 7: e38589.
50. Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA, Sanes JR, Lichtman JW. 2007. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450: 56-62.
51. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ. 2000. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18: 321-325.
52. Luker GD, Sharma V, Pica CM, Dahlheimer JL, Li W, Ochesky J, Ryan CE, Piwnica-Worms H, Piwnica-Worms D. 2002. Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci 99: 6961-6966.
53. Lyons SK, Meuwissen R, Krimpenfort P, Berns A. 2003. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res 63: 7042-7046.
54. Lyons SK, Lim E, Clermont AO, Dusich J, Zhu L, Campbell KD, Coffee RJ, Grass DS, Hunter J, Purchio T, et al. 2006. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice. Cancer Res 66: 4701-4707.
55. 11C]SB207145. Nucl Med Biol 38: 1085-1091.
56. Massoud TF, Paulmurugan R, Gambhir SS. 2010. A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography. Nat Med 16: 921-926.
57. Min JJ, Gambhir SS. 2008. Molecular imaging of PET reporter gene expression. Handb Exp Pharmacol: 277-303.
58. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. 2000. IRESdependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1: 376-382.
59. Mokrejs M, Vopalensky V, Kolenaty O, Masek T, Feketova Z, Sekyrova P, Skaloudova B, Kriz V, Pospisek M. 2006. IRESite: The database of experimentally verified IRES structures (www.iresite.org). Nucleic Acids Res 34: D125-130.
60. Muzic RF Jr, Saidel GM, Zhu N, Nelson AD, Zheng L, Berridge MS. 2000. Iterative optimal design of PET experiments for estimating β-adrenergic receptor concentration. Med Biol Eng Comput 38: 593-602.
61. Najjar AM, Nishii R, Maxwell DS, Volgin A, Mukhopadhyay U, Bornmann WG, Tong W, Alauddin M, Gelovani JG. 2009. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs. J Nucl Med 50: 409-416.
62. Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, et al. 2012. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21: 488-503.
63. Nichols J, Jones K, Phillips JM, Newland SA, Roode M, Mansfield W, Smith A, Cooke A. 2009. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med 15: 814-818.
64. Nicolas G, Giovacchini G, Muller-Brand J, Forrer F. 2011. Targeted radiotherapy with radiolabeled somatostatin analogs. Endocrinol Metab Clin North Am 40: 187-204, ix-x.
65. Okazaki F, Matsunaga N, Okazaki H, Utoguchi N, Suzuki R, Maruyama K, Koyanagi S, Ohdo S. 2010. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice. Cancer Res 70: 6238-6246.
66. Pardo A, Stocker M, Kampmeier F, Melmer G, Fischer R, Thepen T, Barth S. 2012. In vivo imaging of immunotoxin treatment using Katushkatransfected A-431 cells in a murine xenograft tumour model. Cancer Immunol Immunother 61: 1617-1626.
67. Paulmurugan R, Gambhir SS. 2003. Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation. Anal Chem 75: 1584-1589.
68. Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Miething C, Scuoppo C, Zuber J, Dickins RA, Kogan SC, et al. 2011. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145: 145-158.
69. Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipancic I, Zarkovic N. 2006. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett 238: 188-196.
70. Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, Ren BZ, Lahn BT. 2010. Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS ONE 5: e10611.
71. Rabinovich BA, Ye Y, Etto T, Chen JQ, Levitsky HI, Overwijk WW, Cooper LJ, Gelovani J, Hwu P. 2008. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci 105: 14342-14346.
72. + T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 18: 485-498.
73. Ray P, Tsien R, Gambhir SS. 2007. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res 67: 3085-3093.
74. Razansky D, Deliolanis NC, Vinegoni C, Ntziachristos V. 2012. Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery. Curr Pharm Biotechnol 13: 504-522.
75. Safran M, Kim WY, Kung AL, Horner JW, DePinho RA, KaelinWGJr. 2003. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol Imag 2: 297-302.
76. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, et al. 2008. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132: 487-498.
77. + stem cell activity in mouse intestinal adenomas. Science 337: 730-735.
78. Schipper ML, Riese CG, Seitz S, Weber A, Behe M, Schurrat T, Schramm N, Keil B, Alfke H, Behr TM. 2007. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. Eur J Nucl Med Mol Imag 34: 638-650.
79. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22: 1567-1572.
80. Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY. 2009. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 324: 804-807.
81. Singh SP, Han L, Murali R, Solis L, Roth J, Ji L, Wistuba I, Kundra V. 2011. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: Evaluation using an intrathoracic mouse model. Hum Gene Ther 22: 55-64.
82. Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, Barker N, Klein AM, van Rheenen J, Simons BD, et al. 2010. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143: 134-144.
83. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DA. 2004. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol 22: 589-594.
84. Tinkum KL, Marpegan L, White LS, Sun J, Herzog ED, Piwnica-Worms D, Piwnica-Worms H. 2011. Bioluminescence imaging captures the expression and dynamics of endogenous p21 promoter activity in living mice and intact cells. Mol Cell Biol 31: 3759-3772.
85. Toyokuni S. 2009. Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci 100: 9-16.
86. Uhrbom L, Nerio E, Holland EC. 2004. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med 10: 1257-1260.
87. Vande Velde G, Raman Rangarajan J, Vreys R, Guglielmetti C, Dresselaers T, Verhoye M, Van der Linden A, Debyser Z, Baekelandt V, Maes F, et al. 2012. Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain. NeuroImage 62: 367-380.
88. Varma D, Chandrasekaran S, Sundin LJ, Reidy KT, Wan X, Chasse DA, Nevis KR, DeLuca JG, Salmon ED, Cook JG. 2012. Recruitment of the human Cdt1 replication licensing protein by the loop domain of Hec1 is required for stable kinetochore-microtubule attachment. Nat Cell Biol 14: 593-603.
89. Vooijs M, Jonkers J, Lyons S, Berns A. 2002. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 62: 1862-1867.
90. Wang W, El-Deiry WS. 2003. Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol Ther 2: 196-202.
91. Weber K, Thomaschewski M, Warlich M, Volz T, Cornils K, Niebuhr B, Tager M, Lutgehetmann M, Pollok JM, Stocking C, et al. 2011. RGB marking facilitates multicolor clonal cell tracking. Nat Med 17: 504-509.
92. Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, Bogdanov A Jr. 1997. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204: 425-429.
93. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. 2000. In vivo magnetic resonance imaging of transgene expression. Nat Med 6: 351-355.
94. Wolf F, Li W, Li F, Li CY. 2011. Novel luciferase-based reporter system to monitor activation of ErbB2/Her2/neu pathway noninvasively during radiotherapy. Int J Radiat Oncol Biol Phys 79: 233-238.
95. Xu H, Rice BW. 2009. In-vivo fluorescence imaging with a multivariate curve resolution spectral unmixing technique. J Biomed Opt 14: 064011.
96. Yang M, Reynoso J, Bouvet M, Hoffman RM. 2009. A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment. J Cell Biochem 106: 279-284.
97. Zeng Q, Yang Z, Gao YJ, Yuan H, Cui K, Shi Y, Wang H, Huang X, Wong ST, Wang Y, et al. 2010. Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in vivo bioluminescence imaging study. Eur J Cancer 46: 1132-1143.
98. Zhang L, Lee KC, Bhojani MS, Khan AP, Shilman A, Holland EC, Ross BD, Rehemtulla A. 2007. Molecular imaging of Akt kinase activity. Nat Med 13: 1114-1119.
99. Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. 2008. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 283: 33911-33918.
100. 68Ga-DOTATOC. J Nucl Med 52: 123-131.
101. Zhou Y, Rideout WM 3rd, Zi T, Bressel A, Reddypalli S, Rancourt R, Woo JK, Horner JW, Chin L, Chiu MI, et al. 2010. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family-and KRAS-dependent lung adenocarcinomas. Nat Biotechnol 28: 71-78.
102. Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, Lowe SW. 2011. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol 29: 79-83.
103. Zurkiya O, Chan AW, Hu X. 2008. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 59: 1225-1231.